Digital prescription tool to help GPs follow antibiotic guidelines in Belgian primary care
Official title: Impact Evaluation of a Prescription Search Support (PSS) for Antimicrobials Using a Stepped-Wedge Cluster Randomized Design in Belgian Primary Care
Run by KU Leuven · NCT07347015 · Data updated 2026-11-12
This project will test whether a digital Prescription Support System helps general practitioners in Belgium prescribe antibiotics more in line with national guidelines.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | KU Leuven Academic / other |
| Locations | 1 site (Leuven, Vlaams-Brabant) |
| Status | Recruiting |
| Started | December 24, 2025 |
| Main results expected | December 21, 2026 |
| Study ends | March 31, 2027 |
| Registry record updated | July 17, 2026 |
| Trial ID | NCT07347015 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Patients of general practices in Belgium that use a compatible EHR and agree to activate the PSS, particularly those presenting with common infections such as sore throat, bronchitis, sinusitis, ear infections, and urinary tract infections, are the intended population covered by the intervention.
✕Probably not a fit
Patients seen in practices without compatible EHRs, those treated in hospital settings, or those with severe infections clearly requiring antibiotics are unlikely to receive benefit from this primary care PSS implementation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Inappropriate antibiotic prescribing in primary care contributes to antimicrobial resistance, especially for self-limiting infections. The intervention is a Prescription Support System (PSS) that presents Belgian BAPCOC guideline recommendations in a user-friendly decision tree integrated into compatible electronic health record systems. The implementation is being rolled out to participating GP practices using a stepped-wedge cluster randomized design, with practices switching from usual care to the PSS at scheduled intervals. Primary outcomes include changes in antibiotic prescribing for common ambulatory infections and measures of tool uptake and usability.
Why it matters
Potential benefit: If successful, the PSS could reduce unnecessary antibiotic use in primary care, lowering patient harms from side effects and contributing to reduced antimicrobial resistance.
How similar studies have gone: Previous randomized and implementation studies of clinical decision support in primary care have shown modest reductions in inappropriate antibiotic prescribing, and this project builds on a prior mixed-methods usability study of the same PSS.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * General practices in Belgium using compatible EHR systems. * Willingness to use and activate the PSS by giving consent. * Agreement to participate in the study, provided signed informed consent form is in place. Exclusion Criteria: * Practices using an EHR system that solely allows a single sign-on to the standalone PSS. * Practices already using a similar PSS or participating in overlapping projects.
Where it's running
-
GPs associated with KU Leuven
Leuven, Vlaams-Brabant, Belgium Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dietitian-led nutrition care in hospital wards
This trial tests whether having clinical dietitians lead nutritional care for adults in medical wards improves meals, well‑being, and reduces hospital stay and costs.
-
Using awe to encourage adults to take preventive steps like vaccination, mask-wearing, and social distancing
This project will test if feeling awe makes adults in Hong Kong, Singapore, and major Mainland Chinese cities more likely to get vaccinated, wear masks, and keep social distance.
-
Safety and dosing of BWC0977 in healthy adults
This study will test whether single and multiple IV doses of BWC0977 are safe and well tolerated in healthy adults.
-
Long-term monitoring of adults with type I interferon autoantibodies or genetic interferon defects
We will follow adults who have autoantibodies to type I interferons or genetic defects that impair interferon responses to see if they develop more infections or autoimmune problems and how antibody levels change over time.
-
Understanding HIV infection through blood cell studies
This study is testing how HIV affects the immune system by looking at blood samples from people living with the virus to better understand the disease.
-
Gene expression profiles in spinal tuberculosis
This study is trying to see if different gene patterns in spinal tuberculosis can help doctors better understand and treat the disease, especially in people with HIV.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.